SNNAQ — Sienna Biopharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$11.33m
2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -11.3 | -21.2 | -50.5 | -73.5 |
Depreciation | ||||
Non-Cash Items | 1.2 | 0.981 | 7.89 | 8.46 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 0.088 | 2.43 | 1.45 | 3.17 |
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Cash from Operating Activities | -9.98 | -17.7 | -41.1 | -61.7 |
Capital Expenditures | -0.088 | -0.238 | -0.274 | -0.039 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | 0 | -6.82 | 0.008 | 0 |
Acquisition of Business | ||||
Sale of Fixed Assets | ||||
Cash from Investing Activities | -0.088 | -7.06 | -0.266 | -0.039 |
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 14.6 | 28.8 | 107 | 36 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 4.55 | 4.13 | 65.4 | -25.9 |